Page 7 - Pharma Stocks

Lupin shares gain 4% on Tolvaptan Tablets launch in US; details here

Lupin, in a release, said that it holds the exclusive first-to-file status for this product and will have 180-day generic drug exclusivity

Dr Reddy's: Brokerage reports by JM Financial, Motilal Oswal as stock up 4%

DRL's management has guided for double-digit growth in FY26, with margins expected to remain similar to FY25 levels. Here's what brokerages expect from the company going ahead

Dr Reddy's Q4 results preview: Analysts eye 18% jump in PAT; check details

Dr Reddy's Labs Q4 results 2025 date: Dr Reddy's Laboratories is scheduled to announce its fourth quarter (Q4FY25) results on Friday, May 9, 2025

Blue Jet Healthcare jumps 6% as MOFSL initiates coverage, 26% upside seen

Blue Jet Healthcare's stock was quoting at ₹715, up 4.32 per cent on the National Stock Exchange

Mutual Funds increased stake in 14 pharma stocks in Q4FY25; do you own any?

Analysts believe that pharma shares continue to see buying interest, given the inelastic demand for medicines; tariffs, if any could have minimal impact on the industry.

These 3 pharma stocks have surged over 50% in April; check full list here

A total of 11 pharma and healthcare-related stocks have rallied more than 20% thus far in April on hopes of a likely softer tariff-related stance by the US President Donald Trump.

Laurus Labs falls 6% despite strong Q4 results: Here's what brokerages say

Laurus Labs stock was quoting at ₹618.50, down 4.18 per cent from the previous session's closing price of ₹645.50

This smallcap pharma stock surges 10%, nears record high. Do you own?

Vimta Labs shares soared 10% to ₹1,148.15 on the BSE in intra-day trade after the company said its board will meet on Monday, April 28, 2025, to consider a proposal for the issue of bonus shares.

Trend turns favourable for GlaxoSmithKline Pharma, key levels to track

GlaxoSmithKline Pharma stock has seen formation of 'Golden Cross' on the daily chart on Thursday; last time the stock saw a similar development, it rallied almost 117% over the next 14 months.

Sensex rejoices on Trump tariff halt, jumps 1,300 pts; Metals, pharma lead

However, on a weekly basis, the Sensex and Nifty posted a decline of 0.27 per cent and 0.33 per cent, respectively

Biocon subsidiary gets USFDA nod for Everolimus tablets; share zooms 6%

The rise in the Biocon share price came after its wholly-owned unit, Biocon Pharma, received USFDA nod for Everolimus tablets.

Aurobindo Pharma shares jump 4% as arm completes phase1 trial for bone drug

Denosumab works by specifically targeting the RANK ligand (RANKL), a critical protein in the lifecycle of osteoclasts, the cells that break down bone

Cipla share price jumps 5% as USFDA okays cancer drug Paclitaxel

Cipla said USFDA has approved the ANDA submitted for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound), 100 mg/vial, Single-Dose Vial ('Protein-bound Paclitaxel') on Apr 10

Here's why Sun Pharma share price advanced 5% in trade on April 11; details

The rise in the Sun Pharma share price came after a favourable ruling from a US court regarding its planned launch of Leqselvi (deuruxolitinib).

Pharma shares slide up to 10% as Trump to announce pharma tariffs 'soon'

Trump tariffs: Blue Jet Healthcare, Aarti Pharmalabs, Marksans Pharma, Ipca, Wockhardt, Ami Organics, Biocon, Piramal Pharma, Lupin, Laurus Labs and Gland Pharma dropped in the range of 3% to 10%

5 pharma stocks that you should stay away from given their tech charts

Technical charts hint that pharma shares such as Cipla, Lupin, Sun Pharma, Zydus Lifesciences and Gland Pharma could slide up to 23% as Trump tariff threat on pharma import looms.

Here's why Concord Biotech shares gained 5% in trade on April 9; details

The uptick in Concord Biotech share price came after the company was granted final approval from the USFDA for marketing its Teriflunomide Tablets, 7 mg and 14 mg

Here's why Dr. Reddy's share slipped 8%, hit 52-week low on Monday, April 7

The fall in Dr. Reddy's share price came after the company announced that it received approximately Rs 2,395-crore show cause notice from I-T department

Here's why Medicamen Biotech shares skyrocketed 12% in trade on April 3

Medicamen Biotech stock rose following the announcement of a strategic partnership with XGX Pharma, a European company.

Pharma stocks that you can keep in your portfolio despite US tariff woes

Tausif Shaikh, India analyst for pharma and healthcare, BNP Paribas India, prefers domestic-focused companies like Torrent Pharmaceuticals, and JB Chemicals and Pharmaceuticals in the sector